Phase 4 Endometriosis Trial, By Invitation NCT05059626 Sponsor: Penn State University Condition: Endometriosis
Back to Endometriosis

Phase 4 Endometriosis Trial, By Invitation

NCT05059626
By Invitation Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 45 years of age who have been diagnosed with endometriosis through a keyhole surgery procedure performed by their own doctor within the last 10 years
  • People who are currently using Tylenol (paracetamol) for sudden or acute pain may still be eligible
  • People who use an IUD (either copper or hormonal/levonorgestrel type) as contraception may still be eligible

Who may not be able to join:

  • People who use any nicotine-containing products, such as cigarettes, chewing tobacco, or similar
  • People who have diabetes, specifically with a blood sugar control marker (HbA1c) above 6.5%
  • People with high blood pressure above 140/90
  • People who take medications that could affect blood vessel control, such as insulin-sensitising drugs or heart and blood pressure medications
  • People who are currently pregnant
  • People who are currently breastfeeding
  • People who use illicit or recreational drugs
  • People with abnormal liver function
  • People who have a rash, skin condition, skin pigmentation disorder, or known skin allergies
  • People who have been diagnosed with, or are suspected to have, a metabolic or cardiovascular (heart or blood vessel) disease
  • People with persistently unexplained high levels of certain liver enzymes in their blood (confirm with trial site)
  • People with a known allergy to latex or any of the substances used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 4
Sponsor
Penn State University
Registry
ClinicalTrials.gov
Start date
1 December 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in skin blood flow; Change in peripheral blood flow

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov